Essais liés2clinical trials
VilleLimalocalisation
PaysPerulocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT04221477

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Obinutuzumab Lupus Phase 3 NCT04221477 REGENCY — A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis ACTIVE_NOT_RECRUITING
RO7507062 Lupus Phase 1 NCT05835986 A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus ACTIVE_NOT_RECRUITING